Skip to main content
. 2022 Jan 11;12:536. doi: 10.1038/s41598-021-04511-1

Table 1.

Baseline and clinical characteristics between the study groups.

I group (n = 35) LI group (n = 34) p value
Age (years) 57 ± 2 60 ± 2 0.372
Sex (M/F) 18/17 26/8 0.030
Patients ≥ 60 years of age, n % 19 (54) 19 (56) 0.894
Previous T2D, n (%) 25 (71) 21 (62) 0.395
Duration of diabetes (years) 10 ± 1 11 ± 2 0.475
Previous comorbidities, n (%)
Cardiovascular disease 3 (8) 1 (3) 0.319
Chronic kidney disease 6 (17) 4 (12) 0.387
Stroke 0 (0) 2 (5) 0.238
Smoking, n (%) 3 (9) 7 (20) 0.178
Glucose-lowering medications, n (%)
Insulin 4 (11) 5 (15) 0.900
Metformin 13 (37) 16 (47) 0.373
Sulfonylurea 4 (11) 2 (6) 0.414
HBP, n (%) 18 (51) 21 (61) 0.430
Antihypertensive drugs, n (%)
ACE inhibitors 4 (11) 4 (11) 0.916
ARAII 12 (34) 14 (41) 0.522
b-Blockers 6 (17) 3 (9) 0.302
Diuretics 2 (6) 4 (11) 0.365
Calcium-channels b 7 (20) 6 (18) 0.807
Clinical score (0–7) 4.3 ± 0.10 4.3 ± 0.09 0.873
Weight (kg) 80 ± 3 81 ± 3 0.934
BMI (kg/m2) 30.8 ± 1.2 31.1 ± 1.5 0.875
HbA1c (%) 8.9 ± 0.3 8.4 ± 0.4 0.439
Glucose (mg/dl) 251 ± 15 251 ± 21 0.993
Serum creatinine (mg/dl) 1.3 ± 0.2 1.2 ± 0.2 0.505
Total cholesterol (mg/dl) 161 ± 8 165 ± 9 0.722
LDL cholesterol (mg/dl) 86 ± 5 89 ± 8 0.783
HDL cholesterol (mg/dl) 31 ± 2 29 ± 2 0.409
Triglycerides (mg/dl) 216 ± 15 213 ± 16 0.894
Lymphocyte count (mu/l) 903 ± 100 981 ± 93 0.577
CRP (mg/l) 146 ± 21 131 ± 23 0.637
D-dimer (ng/ml) 663 ± 174 1018 ± 266 0.256
LDH (units/l) 478 ± 45 445 ± 37 0.583
Ferritin (ng/ml) 675 ± 98 889 ± 221 0.376
AST (U/l) 59 ± 13 61 ± 12 0.904
ALT (U/l) 49 ± 9 56 ± 14 0.693
Albumin (g/dl) 3.1 ± 0.1 3.0 ± 0.1 0.367
Oxygen saturation (%) 92 ± 0.7 92 ± 0.8 0.838

Data are mean ± SEM.

CRP C reactive protein, LDH lactate dehydrogenase, AST aspartate aminotransferase, ALT alanine aminotransferase.